REFERENCES
- Thames HD, Peters LJ, Withers HR, Fletcher GH. Acceler-ated fractionation vs hyperfractionation rationales for several treatments per day. Int .1- Radiat Oncol Biol Phys 1983; 9: 127–38.
- Saunders MI, Dische S. Radiotherapy employing three frac-tions in each day over a continuous period of 12 days. Br J Radiol 1986; 59: 523–5.
- Van den Bogaert W, Van Der Schueren E, Horiot JC, et al. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. Int j Radiat Oncol Biol Phys 1982; 8: 1649–55.
- Fowler JF. What next in fractionated radiotherapy? Br J Cancer 1984; 49 (Suppl 6): 285–300.
- Dische S, Saunders MI. Continuous, hyperfractionated, accel-erated radiotherapy (CHART): an interim report upon late morbidity. Radiother Oncol 1989; 16: 65–72.
- Leslie MD, Dische S. Parotid gland function following accel-erated and conventionally fractionated radiotherapy. Radio-ther Oncol 1991; 22: 133–9.
- Lartigau E, Saunders MI, Dische S, Warburton MF, Des Rochers CA. A comparison of the late radiation changes after three schedules of radiotherapy. Radiother Oncol 1991; 20: 139–48.
- Turner SL, Lochrin CA, Dische S, Saunders MI, Maher EJ. Continuous hyperfractionated accelerated radiotherapy in the treatment of carcinoma of the columella and vestibule of the nose. Eur J Cancer 1995; 31B: 368–72.
- Saunders M, Dische S, Barrett A, Harvey A, Gibson A, Parmar M, on behalf of the CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. Lancet 1997; 350: 161–6.
- Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M, on behalf of the CHART Steering Committee. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997; 44: 123–36.
- Horiot J-C, Bontemps P, van den Bogaert W, et al. Acceler-ated fractionation (AF) compared to conventional fractiona-tion (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997; 44: 111–21.
- Maciejewski B, Skladowski K, Pilecki B, et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 1996; 40: 137–45.